Listen: Europe’s vaccine safety scare, Lilly’s Alzheimer’s data, & a plea for transparency

Has Europe lost the plot with Covid-19 vaccines? Can the latest treatment for Alzheimer’s disease succeed where so many others failed? And why don’t biotech companies just come clean when things go wrong?

We discuss all that and more this week on “The Readout LOUD,” STAT’s biotech podcast. First we unpack the crisis of confidence facing AstraZeneca’s Covid-19 vaccine in Europe with Alison Buttenheim, a University Pennsylvania professor who studies vaccine acceptance. Then, we explain the latest data on an Alzheimer’s disease treatment from Eli Lilly and why it has polarized experts in the field. Finally, we make a modest proposal to the biotech industry: Give honesty a chance.

Read the rest…

Listen: Europe’s vaccine safety scare, Lilly’s Alzheimer’s data, & a plea for transparency

Leave a Reply

Your email address will not be published. Required fields are marked *

Scroll to top